162221-28-5 Usage
Uses
Used in Organic Synthesis:
[(4S,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl]methyl 4-nitrobenzenesulfonate is used as a protecting group for amines in organic synthesis for the protection of amine functional groups during chemical reactions. This protection is crucial to prevent unwanted side reactions and ensure the selective formation of the desired product.
Used as a Precursor in Organic Synthesis:
In the field of chemical research, [(4S,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl]methyl 4-nitrobenzenesulfonate is used as a precursor for the synthesis of various organic compounds. Its unique structure and functional groups make it a suitable starting material for the development of new molecules with potential applications in various industries, such as pharmaceuticals, materials science, and agrochemicals.
Used in Chemical Research:
[(4S,5S)-4-benzyl-2-oxo-1,3-oxazolidin-5-yl]methyl 4-nitrobenzenesulfonate is utilized in chemical research to explore its reactivity and potential applications in the synthesis of complex molecules. Researchers in academia and industry are interested in its ability to undergo selective reactions and functional group transformations, which can lead to the discovery of new synthetic methods and the development of novel compounds with specific properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 162221-28-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,2,2 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 162221-28:
(8*1)+(7*6)+(6*2)+(5*2)+(4*2)+(3*1)+(2*2)+(1*8)=95
95 % 10 = 5
So 162221-28-5 is a valid CAS Registry Number.
162221-28-5Relevant articles and documents
Synthesis of the HIV-proteinase inhibitor Saquinavir: A challenge for process research
G?hring, Wolfgang,Gokhale, Surendra,Hilpert, Hans,Roessler, Felix,Schlageter, Markus,Vogt, Peter
, p. 532 - 537 (2007/10/03)
The task of process research, namely developing efficient, economically and technically as well as ecologically feasible syntheses in time, is demonstrated on the HIV-proteinase inhibitor Saquinavir (1), a complex molecule comprising six stereo-centres. Based on the first 26-step research synthesis furnishing a 10% overall yield, process research established a new, short 11-step synthesis affording a 50% overall yield.